International Psoriasis Council

Advancing Knowledge. Enhancing Care.

Advancing Knowledge. Enhancing Care.

2022_think_tank_header_(12)

2022 IPC THINK TANK | MIAMI, FLORIDA

HOTEL AKA BRICKELL
1395 BRICKELL AVE
MIAMI, FL 33131

Friday, December 9

10:30 AM OPENING

WELCOME AND OPENING REMARKS

Craig Leonardi, MD, United States

SYMPOSIUM: WHAT'S NEXT IN PSORIASIS? FROM MAINTENANCE TO DISEASE MODIFICATION

Disease Modification of Psoriasis and Its Comorbidities
MODERATOR: Bruce Strober, MD, PhD, United States

Efficacy of Biologics in Terms of True Disease Modification – Ken Gordon, MD, United States
Personalized Treatment in the Management of Comorbidities – Kevin Cooper, MD, United States

Pathomechanism of Disease Memory in Psoriasis
MODERATOR: Siew Eng Choon, MBBS, FRCP, Malaysia

What is the Disease Memory in Psoriasis? – Johann Gudjonsson, MD, PhD, United States
How to KNOCK OUT Disease Memory? – Andrew Blauvelt, MD, MBA, United States

12:45 PM LUNCH

Early Intervention and Disease Modification
MODERATOR: Joel Gelfand, MD, MSCE, United States

Real Life Data on Early Intervention in Psoriasis – Christopher Griffiths, OBE, MD, FRCP, FMedSci, United Kingdom
Biomarkers in the Long-Term Management of Psoriasis – Catherine Smith, MD, United Kingdom

2:50 PM BREAK

Diversity and Psoriasis
MODERATOR: Mahira El Sayed, MSc, MD, Egypt

Skin of Color and Psoriasis – Andrew Alexis, MD, United States
Genetic Heterogeneity of Psoriasis – Jonathan Barker, MD, FRCP, United Kingdom

KEYNOTE: A Vision on Long-term Management of Psoriasis
INTRODUCTION: Hervé Bachelez, MD, PhD, France

Craig Leonardi, MD, United States

CLOSING

Craig Leonardi, MD, United States

5:00 - 6:30 PM RECEPTION